Brief: Sk Biopharmaceuticals Co Q2 Operating. Profit 97 Billion Won, Up 57% Y/Y
05/08/2026 01:51
BRIEF-Sk Biopharmaceuticals Co Q2 Operating. Profit 97 Billion Won, Up 57% Y/Y SK Biopharmaceuticals Co Ltd 326030.KS:
Q2 OPERATING. PROFIT 97 BILLION WON, UP 57% Y/Y
Source text: [ID:]
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker